Potential medication mix-ups between Inflectra and Zymfentra prompt safety warnings
The Institute for Safe Medication Practices (ISMP), an affiliate of ECRI, has raised concerns about potential medication errors involving two biologic drugs approved by the Food and Drug Administration (FDA). Read More »